ImageneBio, Inc.

Contributing Author

Recent Articles by ImageneBio, Inc.

Apr-13	ImageneBio Announces $30 Million Private Placement IMA +23.42% GlobeNewswire
Mar-17	ImageneBio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) IMA GlobeNewswire
Mar-10	ImageneBio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Company Update IMA GlobeNewswire
Feb-26	ImageneBio to Participate in Leerink Global Healthcare Conference IMA GlobeNewswire
Feb-10	ImageneBio Appoints Immunology Drug Development Veteran Dr. Ben Porter-Brown as Chief Medical Officer IMA GlobeNewswire
Nov-12	ImageneBio Reports Third Quarter 2025 Financial Results and Provides IMG-007 Program Update Following Closing of Reverse Merger, Concurrent Financing, and Strengthening of Management Team IMA GlobeNewswire
Nov-06	ImageneBio to Participate in Fourth Quarter 2025 Investor Conferences IMA GlobeNewswire
Aug-01	ImageneBio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) IMA GlobeNewswire